April 13, 2026 a 11:44 am**DGX: Fibonacci Analysis - Quest Diagnostics Incorporated**
**Fibonacci Analysis**
The most recent trend for Quest Diagnostics Incorporated's stock (DGX) is a pronounced upward movement. Technical analysis reveals that the stock experienced a clear upswing from early January 2026 to early April 2026, reaching significant support and resistance levels.
**Fibonacci Retracement Levels**
Calculated based on the high of $211.91 and low of $186.85:
**Analysis**
The current stock price of $191.51 is nearing the Fibonacci retracement level of 0.618 ($193.46). This suggests the stock is in a potential support zone, which may result in a price correction or reversal.
**Interpretation**
Technically, the 0.618 Fibonacci level is often regarded as a strong support level. If the price holds above this level, the upward trend may continue. Conversely, if it breaks below, further declines could ensue.
**Conclusion**
Quest Diagnostics (DGX) showcases a robust upward price trend identified in recent months. The Fibonacci levels indicate critical areas for potential support and resistance. While the 0.618 level represents a strong technical support, a violation could signify further declines. Investors should remain cautious and consider these technical levels while making investment decisions. The stock provides potential growth opportunities, but also comes with risks of volatility, particularly around key Fibonacci retracement levels.
Quest Diagnostics Incorporated provides a comprehensive range of diagnostic testing, information, and services both in the United States and internationally. The company's stock, identified by the ticker DGX, has recently shown a dominant trend. After a careful review of historical price data, an upward trend is evident. This upward trend presents potential opportunities for investors, especially when combined with technical analysis tools like Fibonacci retracement to identify price levels of interest.
| Start Date | End Date | High Date | High Price | Low Date | Low Price |
|---|---|---|---|---|---|
| 2025-11-05 | 2026-03-02 | 2026-02-27 | 211.91 | 2025-11-12 | 186.85 |
| Level | Price |
|---|---|
| 0.236 | 203.67 |
| 0.382 | 199.30 |
| 0.5 | 196.38 |
| 0.618 | 193.46 |
| 0.786 | 189.10 |
**Conclusion**
Quest Diagnostics (DGX) showcases a robust upward price trend identified in recent months. The Fibonacci levels indicate critical areas for potential support and resistance. While the 0.618 level represents a strong technical support, a violation could signify further declines. Investors should remain cautious and consider these technical levels while making investment decisions. The stock provides potential growth opportunities, but also comes with risks of volatility, particularly around key Fibonacci retracement levels.